Delivery Order 75N93020D00007-75N93024F00002
- The National Institute of Allergy and Infectious Diseases awarded a delivery order valued at $2.18M to The Administrators of Tulane Educational Fund (doing business as Tulane University) on April 1, 2020, to conduct Study P223. This cost-plus-no-fee delivery order falls under the Simian Vaccine Evaluation Units indefinite delivery contract and is scheduled for completion by December 24, 2027. The work will be performed in New Orleans, Louisiana, where Tulane maintains its National Primate...
- This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Tulane University for $1,539,493.90 to provide administrative and technical support for the Simian Vaccine Evaluation Units (SVEUS) program. The contract has an ultimate completion date of March 31, 2027 and is a cost-no-fee type contract. Tulane University is a private, non-profit research university with extensive experience providing research, educational, and technical...
- This is a federal contract award to The Administrators Of Tulane Educational Fund, doing business as Tulane University, by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency. The contract, valued at $3,675,463.09, is a delivery order under the Simian Vaccine Evaluation Units (SVEUS) major program. It does not have a set-aside designation. The contract supports NIAID's mission of advancing research to understand, prevent, and treat infectious diseases by...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to The Administrators of Tulane Educational Fund, doing business as Tulane University. The contract is a delivery order under the "Simian Vaccine Evaluation Units 2013-2020" indefinite delivery contract, with a ceiling value of $9,035,728.24 and a completion date of April 30, 2022. The contract is for "Simian...
- This is a delivery order award to The Administrators Of Tulane Educational Fund, doing business as Tulane University, under the National Institute of Allergy and Infectious Diseases' (NIAID) Simian Vaccine Evaluation Units master contract. The $1,796,343 award is for a study titled "CONDUCT STUDY P217" with a period of performance through October 30, 2026. The contract does not have a set-aside designation. As a comprehensive research university, Tulane University has extensive...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,041,214 delivery order contract to Tulane University to conduct a study titled "CONDUCT STUDY P214". This contract is under NIAID's Simian Vaccine Evaluation Units (SVEUS) Indefinite Delivery Contract (IDC), a $146,300,000 multiple-award vehicle for preclinical research support services. The contract has a period of performance through July 23, 2026 and does not contain a set-aside designation. Tulane...
- This $1,422,288.62 federal delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the Administrators of Tulane Educational Fund, doing business as Tulane University, a private university in New Orleans, Louisiana. The contract is for "Simian Vaccine Evaluation Units" and has an ultimate completion date of June 30, 2020. It is a cost-no-fee contract issued under a...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $645,369.00 delivery order to The Administrators of the Tulane Educational Fund, doing business as Tulane University, on August 5, 2019. The award, which is not set aside, is for the Conduct Study P209 under the Simian Vaccine Evaluation Units 2013-2020 master contract vehicle. Tulane University, a private non-profit university located in New...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $6.5 million delivery order to The Administrators of the Tulane Educational Fund, doing business as Tulane University, to serve as the Nonhuman Primate Studies Coordination Center in support of COVID-19-related research at the National Primate Research Centers. This delivery order was issued against the Simian Vaccine Evaluation Units indefinite-delivery/indefinite-quantity master contract to...
- This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to The Administrators of Tulane Educational Fund, doing business as Tulane University. The $150,969.93 award provides administrative and technical support for ongoing studies and the final transition under the Simian Vaccine Evaluation Units program, which is a major program code associated with this contract. The...
- Simian Vaccine Evaluation UnitsMaster IDIQ
- 75N93020D00007Indefinite Delivery Contract
- 75N93020D00007-75N93024F00002Delivery Order
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $1.72 million to The Administrators of Tulane Educational Fund, doing business as Tulane University, on September 13, 2024, for Conduct Study 222 under the Simian Vaccine Evaluation Units program. This cost-plus-no-fee delivery order is scheduled for completion by April 11, 2027, with work to be performed in New Orleans, Louisiana. The award carries no set-aside designation, reflecting Tulane's competitive capabilities in this specialized research domain. This delivery order is issued under the parent contract vehicle for Simian Vaccine Evaluation Units, leveraging Tulane's extensive infrastructure and expertise in vaccine development and evaluation research. Tulane University, home to the Tulane National Primate Research Center—one of seven NIH-funded National Primate Research Centers—brings substantial expertise to vaccine evaluation and infectious disease research. The institution has established a strong track record with NIAID, including prior awards of $22.6 million for operation of the Cellular Immunology Core Laboratory and substantial funding under a $146.3 million indefinite delivery contract for preclinical infectious disease models. This delivery order supports NIAID's mission to conduct critical vaccine evaluation studies, building on Tulane's demonstrated capabilities in biomedical research infrastructure, specialized scientific services, and collaborative research networks that position the institution as a key federal research partner.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Other Administrative Action | $0 | 1/29/26 | |
| P00002 | Change Order | $0 | 8/29/25 | |
| P00001 | Other Administrative Action | $0 | 5/8/25 | |
| Not listed | Not listed | $1.7m | 9/10/24 |